Hydrogel matrix for cellular tissue storage
Abstract
(57) the matrix containing the cell ingredient which produces hormone which is equipment for effective discharge of a cell ingredient including summary hormone, and is contained in it, Passage of an immunogenicity substance is intercepted and the wrapper of the effective nutritive substance for the hormone produced by this cell ingredient and it is carried out with the non-immunogenicity polymer material of the ingredient of the poly パラキシリレン which has a part equipped with the porosity which can make it pass to wind, or other aromatic series bases. The hydrogel of the collagen base which is a matrix which has improved for preservation of a cell ingredient, manufacture, a functional test, and a viral infection examination, and is included in it, An effective additive is included, in order that it may be processed as host temperature shows the liquid phase, and it may function as a matrix for cell adhesion and this matrix may restrict damage by heat and 圧. Furthermore, how to have been improved for separating an organization from an organ.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
84 members in 12 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 56869495 | United States of America | A | |
| 9618209 | United States of America | W |
Members84
| Document | Office | Kind | |
|---|---|---|---|
| CA2109065A1 | Canada | A1 | |
| WO9316685A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU3729693A | Australia | A | |
| NO933844D0 | Norway | D0 | |
| NO933844L | Norway | L | |
| EP0587840A1 | European Patent Office (EPO) | A1 | |
| JPH06509812A | Japan | A | |
| EP0587840A4 | European Patent Office (EPO) | A4 | |
| AU663938B2 | Australia | B2 | |
| US5614205A | United States of America | A | |
| CA2239498A1 | Canada | A1 | |
| WO9720569A2 | World Intellectual Property Organization (WIPO) | A2 | |
| ZA9610297B | South Africa | B | |
| AU1119297A | Australia | A | |
| WO9720569A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO9832841A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU6029298A | Australia | A | |
| EP0865288A2 | European Patent Office (EPO) | A2 | |
| US5824331A | United States of America | A | |
| US5830492A | United States of America | A | |
| US5834005A | United States of America | A | |
| US5908633A | United States of America | A | |
| EP0587840B1 | European Patent Office (EPO) | B1 | |
| AU714465B2 | Australia | B2 | |
| CA2332701A1 | Canada | A1 | |
| CA2337047A1 | Canada | A1 | |
| CA2337051A1 | Canada | A1 | |
| DE69327281D1 | Germany | D1 | |
| WO0002596A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO0002600A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO0002999A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU4977299A | Australia | A | |
| AU4977399A | Australia | A | |
| AU5095299A | Australia | A | |
| WO0002999A3 | World Intellectual Property Organization (WIPO) | A3 | |
| JP2000507202A | Japan | A | |
| DE69327281T2 | Germany | T2 | |
| NO309124B1 | Norway | B1 | |
| EP1094849A1 | European Patent Office (EPO) | A1 | |
| EP1096962A1 | European Patent Office (EPO) | A1 | |
| US6231881B1 | United States of America | B1 | |
| EP1098959A2 | European Patent Office (EPO) | A2 | |
| US2001007658A1 | United States of America | A1 | |
| US6261587B1 | United States of America | B1 | |
| US2001010826A1 | United States of America | A1 | |
| US2001019841A1 | United States of America | A1 | |
| US6315994B2 | United States of America | B2 | |
| US6352707B1 | United States of America | B1 | |
| JP3291297B2 | Japan | B2 | |
| JP2002520013A | Japan | A | |
| AU756049B2 | Australia | B2 | |
| AU757968B2 | Australia | B2 | |
| AU758833B2 | Australia | B2 | |
| EP1321516A2 | European Patent Office (EPO) | A2 | |
| EP1321516A3 | European Patent Office (EPO) | A3 | |
| FI111335B | Finland | B | |
| EP0865288B1 | European Patent Office (EPO) | B1 | |
| CA2239498C | Canada | C | |
| AT247478TThis record | Austria | T | |
| ATE247478T1 | Austria | T1 | |
| DE69629583D1 | Germany | D1 | |
| CA2109065C | Canada | C | |
| US6713079B2 | United States of America | B2 | |
| US6730315B2 | United States of America | B2 | |
| DE69629583T2 | Germany | T2 | |
| JP3606585B2 | Japan | B2 | |
| EP1321516B1 | European Patent Office (EPO) | B1 | |
| AT321126T | Austria | T | |
| ATE321126T1 | Austria | T1 | |
| DE69635940D1 | Germany | D1 | |
| EP1094849B1 | European Patent Office (EPO) | B1 | |
| AT326243T | Austria | T | |
| ATE326243T1 | Austria | T1 | |
| DE69931371D1 | Germany | D1 | |
| DE69635940T2 | Germany | T2 | |
| CA2337047C | Canada | C | |
| CA2337051C | Canada | C | |
| DE69931371T2 | Germany | T2 | |
| EP1096962B1 | European Patent Office (EPO) | B1 | |
| AT449619T | Austria | T | |
| ATE449619T1 | Austria | T1 | |
| DE69941707D1 | Germany | D1 | |
| CA2332701C | Canada | C | |
| ES2337320T3 | Spain | T3 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 96941993
Titles2
- German
- BIOARTIFIZIELLE VORRICHTUNGEN UND HIERFÜR VERWENDETE ZELLHALTIGE MATRIX
- English
- BIOARTIFICIAL DEVICES AND CEREAL MATRIX USED THEREFOR
Classification
- CPC, 24
- A61K9/0024
- A01N1/02
- A01N1/0231
- A61F2/022
- A61F2310/00365
- A61K35/12
- A61K38/00
- A61K2035/126
- A61L27/222
- A61L27/24
- A61L27/26
- A61L27/38
- C12N5/0012
- A61P3/00
- C12N5/0676
- A61P3/10
- C12N5/0677
- A61P39/00
- C12N2500/05
- C12N2500/32
- C12N2509/00
- C12N2533/30
- C12N2533/54
- C12N2533/70
- IPC, 24
- A01N1 02
- A61F2 00
- A61F2 02
- A61K31 00
- A61K35 12
- A61K35 37
- A61K35 39
- A61K38 00
- A61K38 17
- A61K47 16
- A61K47 36
- A61K47 42
- A61K9 00
- A61K9 06
- A61L27 00
- A61L27 22
- A61L27 24
- A61L27 26
- A61L27 38
- A61P3 00
- A61P3 10
- A61P39 00
- C12N5 00
- C12N5 071